Nucala 100 MG/ML auto-injectorml

Ended Awarded

Contract number
SPE2DR26FCTC8
Awardee
Awarding agency
Obligated
$11,591

Award facts

Contract value 100% obligated
$11,591.04 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on July 8, 2026, with a ceiling value of $11,591.04 for Nucala 100 mg/mL auto-injector. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award indefinite delivery contract with a $499.999 billion ceiling running through December 31, 2036.

Place of performance is Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business. The order is priced on a firm fixed-price basis with an ultimate completion date of July 9, 2026.

Quick answers

Who was awarded contract SPE2DR26FCTC8?

SPE2DR26FCTC8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 8, 2026.

How much is contract SPE2DR26FCTC8 worth?

The government has obligated $11,591 on SPE2DR26FCTC8.

Is contract SPE2DR26FCTC8 an order under another contract?

Yes. SPE2DR26FCTC8 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.

Was contract SPE2DR26FCTC8 competed?

The extent of competition for SPE2DR26FCTC8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login